Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionColdstream Capital Management Inc
Latest Disclosed Ownership35,580 shares
Latest Disclosed Value $ 4,958,699
Coldstream Capital Management Inc reports 7.01% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 8, 2026 - Coldstream Capital Management Inc filed a 13F-HR form disclosing ownership of 35,580 shares of Gilead Sciences, Inc. (CH:GILD) valued at $4,958,699 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 38,262 shares of Gilead Sciences, Inc.. This represents a change in shares of -7.01% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F GILEAD SCIENCES COM 375558103 35,580 -2,682 -7.01 4,959 5.58 0.0532
2026-02-09 2025-12-31 13F GILEAD SCIENCES COM 375558103 38,262 2,536 7.10 4,696 18.44 0.0605
2025-11-19 2025-09-30 13F GILEAD SCIENCES COM 375558103 35,726 8,807 32.72 3,966 32.88 0.0534
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 26,919 1,651 6.53 2,985 5.40 0.0488
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 25,268 890 3.65 2,831 25.77 0.0603
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 24,378 1,496 6.54 2,252 16.51 0.0480
2024-11-18 2024-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 22,882 2,043 9.80 1,932 35.20 0.0418
2024-11-18 2024-09-30 13F GILEAD SCIENCES COM 375558103 22,882 1,932
2024-08-07 2024-06-30 13F GILEAD SCIENCES COM 375558103 20,839 -2,121 -9.24 1,430 -14.99 0.0348
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 22,960 1,816 8.59 1,682 -1.81 0.0427
2024-02-09 2023-12-31 13F GILEAD SCIENCES COM 375558103 21,144 2,552 13.73 1,713 22.90 0.0479
2023-11-02 2023-09-30 13F GILEAD SCIENCES COM 375558103 18,592 -475 -2.49 1,393 -5.17 0.0455
2023-08-03 2023-06-30 13F GILEAD SCIENCES COM 375558103 19,067 -223 -1.16 1,469 -8.19 0.0466
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 19,290 50 0.26 1,600 -3.09 0.0537
2023-01-10 2022-12-31 13F GILEAD SCIENCES COM 375558103 19,240 5,376 38.78 1,652 92.65 0.0605
2022-08-08 2022-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 13,864 5,710 70.03 857 76.70 0.0334
2022-08-08 2022-06-30 13F GILEAD SCIENCES COM 375558103 8,281 127 512 0.0218
2022-05-11 2022-03-31 13F GILEAD SCIENCES COM 375558103 8,154 -5,978 -42.30 485 -52.73 0.0167
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 14,132 7,040 99.27 1,026 129.02 0.0322
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 7,092 -994 -12.29 448 -19.57 0.0217
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 8,086 1,645 25.54 557 33.89 0.0224
2021-06-16 2021-03-31 13F GILEAD SCIENCES COM 375558103 6,441 -601 -8.53 416 1.46 0.0244
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 7,042 507 7.76 410 -0.73 0.0247
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,535 -2,065 -24.01 413 -37.61 0.0344
2020-08-12 2020-06-30 13F GILEAD SCIENCES COM 375558103 8,600 -940 -9.85 662 -7.15 0.0594
2020-05-27 2020-03-31 13F GILEAD SCIENCES COM 375558103 9,540 2,195 29.88 713 49.48 0.0779
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 7,345 -344 -4.47 477 -2.05 0.0391
2019-11-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 7,689 640 9.08 487 2.31 0.0410
2019-08-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 7,049 285 4.21 476 8.18 0.0396
2019-05-10 2019-03-31 13F GILEAD SCIENCES COM 375558103 6,764 605 9.82 440 14.29 0.0385
2019-02-26 2018-12-31 13F GILEAD SCIENCES COM 375558103 6,159 -1,375 -18.25 385 -33.85 0.0374
2018-11-14 2018-09-30 13F GILEAD SCIENCES COM 375558103 7,534 881 13.24 582 23.57 0.0527
2018-08-14 2018-06-30 13F GILEAD SCIENCES COM 375558103 6,653 -887 -11.76 471 -17.08 0.0476
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 7,540 613 8.85 568 14.52 0.0613
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 6,927 569 8.95 496 -3.69 0.0538
2017-11-15 2017-09-30 13F GILEAD SCIENCES COM 375558103 6,358 -21 -0.33 515 13.94 0.0599
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 6,379 -35 -0.55 452 3.67 0.0583
2017-05-09 2017-03-31 13F GILEAD SCIENCES COM 375558103 6,414 252 4.09 436 -1.13 0.0602
2017-02-09 2016-12-31 13F GILEAD SCIENCES COM 375558103 6,162 3,488 130.44 441 108.02 0.0718
2016-11-14 2016-09-30 13F/A-2 GILEAD SCIENCES COM 375558103 2,674 -3,555 -57.07 212 -59.23 0.0376
2016-11-14 2016-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 2,674 -3,555 212 0.0376
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 2,674 -3,555 212 0.0376
2016-08-09 2016-06-30 13F GILEAD SCIENCES COM 375558103 6,229 -285 -4.38 520 -13.04 0.0921
2016-05-16 2016-03-31 13F GILEAD SCIENCES COM 375558103 6,514 -280 -4.12 598 -12.95 0.1089
2016-02-04 2015-12-31 13F GILEAD SCIENCES COM 375558103 6,794 99 1.48 687 4.57 0.1492
2015-11-09 2015-09-30 13F GILEAD SCIENCES COM 375558103 6,695 366 5.78 657 -11.34 0.1756
2015-07-31 2015-06-30 13F GILEAD SCIENCES COM 375558103 6,329 6,329 741 0.1938
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.